000 01308 a2200349 4500
005 20250511191701.0
264 0 _c19920327
008 199203s 0 0 eng d
022 _a0002-9629
024 7 _a10.1097/00000441-199202000-00004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMuirhead, E E
245 0 0 _aBiologic differences between vasodilator prostaglandins and medullipin I.
_h[electronic resource]
260 _bThe American journal of the medical sciences
_cFeb 1992
300 _a86-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDinoprostone
_xpharmacology
650 0 4 _aEpoprostenol
_xpharmacology
650 0 4 _aLipids
_xpharmacology
650 0 4 _aProstaglandins
_xpharmacology
650 0 4 _aProstaglandins A
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred SHR
650 0 4 _aVasodilator Agents
_xpharmacology
700 1 _aBrooks, B
700 1 _aByers, L W
773 0 _tThe American journal of the medical sciences
_gvol. 303
_gno. 2
_gp. 86-9
856 4 0 _uhttps://doi.org/10.1097/00000441-199202000-00004
_zAvailable from publisher's website
999 _c1546099
_d1546099